Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis

Gut24.50
Volume: 54, Issue: 7, Pages: 966 - 971
Published: Jul 1, 2005
Abstract
Background and aims: null We examined the hypothesis of an anti-inflammatory effect of phosphatidylcholine in ulcerative colitis. null null Methods: null A phase IIA, double blind, randomised, placebo controlled study was performed in 60 patients with chronic active, non steroid dependent, ulcerative colitis, with a clinical activity index (CAI) of ⩾4. Retarded release phosphatidylcholine rich phospholipids and placebo were administered at a...
Paper Fields
Paper Details
Title
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
Published Date
Jul 1, 2005
Journal
Volume
54
Issue
7
Pages
966 - 971
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.